Novartis AG's Fiscal Year is From January To December - All Figures are in USD, Billions.
The item "Total-Long-Term-Debt" stands at 24.24 Billion United States Dollars as of 09/30/2025.
As of the end of Novartis AG's third quarter, the item "Total Long Term Debt" stands at 24.24 Billion USD. This represents an increase of 0.72 percent compared to it's value at the end of it's second quarter .
Regarding the One-Year-Change of the series, the current value constitutes a decrease of -5.29 percent compared to the value the year prior.
The 1 year change in percent is -5.29.
The 3 year change in percent is 14.14.
The 5 year change in percent is -14.80.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Total Long Term Debt | 905,699,262,464.00 |
![]() | Johnson & Johnson - Total Long Term Debt | 486,508,953,600.00 |
![]() | AbbVie Inc - Total Long Term Debt | 399,570,305,024.00 |
![]() | Roche Holding AG - Total Long Term Debt | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Total Long Term Debt | 280,205,508,085.11 |